Analyzing breast milk and feces from mother-infant pairs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect breast milk and fecal samples from healthy mother-infant pairs to investigate the microbial and metabolomic signatures present in these specimens. By utilizing advanced culture techniques and omics sequencing technology, the study seeks to uncover insights into the health and development of infants. The focus is on understanding the relationship between maternal health and the microbial environment of breast milk and feces. The findings could provide valuable information for improving infant health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* healthy pregnant women aged between 20y and 40y.
* Vaginal birth
* BMI\<23.5 before pregnancy
* Infants' birth weight, between 2500g and 4000g.

Exclusion Criteria:

* gestational diabetes
* diagnosis of depressive disorder during pregnancy
* gestational hypertension
* diagnosis of other diseases during pregnancy
* Under probiotics or antibiotic treatment from 3 months prior to pregnancy till 3 months after delivery
* histrory of smoking and drinking alcohol
* history of diarrhea from 3 months prior to pregnancy till 3 months after delivery

Where it's running

• Zhujiang Hospital
  Guangzhou, Guangdong, China Recruiting

Study contacts

• Study coordinator: Ying Ma, Doctor
• Email: mayingwuzhuoyi@126.com
• Phone: 13113361169

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Restore a newborn's gut microbiota using the mother's microbes.

  This will test whether giving C-section newborns bacteria from their own mother or commercial probiotics helps their gut microbiota become more like babies born vaginally.

  Recruiting at 2 sites University of Helsinki · Helsinki and 1 other locations · NCT07212361

• Rivaroxaban in breast milk after maternal dosing

  This will test how much rivaroxaban passes into breast milk in postpartum people taking either prophylactic (10 mg) or therapeutic (20 mg) doses.

  Recruiting Phase 1 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT06831474

• Study on mother-infant gut health in Malaysia and China

  This study looks at how the types of bacteria in breast milk from mothers in Malaysia and China might affect their babies' health and development during the first year of life.

  Recruiting Universiti Putra Malaysia · Kajang, Selangor · NCT04919265

• Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?

  This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.

  Recruiting Applied Science & Performance Institute · Tampa, Florida · NCT07760506

• NVTIA Ergothioneine for Healthy Aging and Skin Health

  This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.

  Recruiting European Life Science Research Association · Dhaka · NCT07750002

• Miricell supplementation and markers of healthy aging

  This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.

  Recruiting Nutraland USA, Inc. · Canfield, Ohio · NCT07675200

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.